Gateway Foundation Swansea - Belleville Illinois

Gateway Foundation Swansea - Belleville, IL

Gateway Foundation Swansea is treatment facility located at 1 Bronze Pointe Boulevard, Suite 1 in the 62226 zip code in Belleville, IL that offers medication assisted substance abuse treatment. It accepts adult women, people with co-occurring substance use and mental disorders and adult men into its treatment program. Gateway Foundation Swansea provides suboxone prescription, buprenorphine detox and buprenorphine maintenance to children and adolescents. Some of the treatment approaches used by Gateway Foundation Swansea consist of matrix Model, dialectical behavior therapy and anger management. Gateway Foundation Swansea also includes detox services and offers opioid detox and alcohol detox.

Address: 1 Bronze Pointe Boulevard, Suite 1, Belleville, IL 62226

  1. Types of Care
  2. Service Settings
  3. Opioid Medications used in Treatment
  4. Type of Alcohol Use Disorder Treatment
  5. Type Of Treatment
  6. Pharmacotherapies
  7. Treatment Approaches
  8. FacilityOwnership
  9. License/Certification/Accreditation
  10. Payment/Insurance/Funding Accepted
  11. Special Programs/ Population Groups Supported
  12. Assessment/Pre-treatment
  13. Screening & Testing
  14. Transitional Services
  15. Ancillary Services
  16. Detoxification
  17. Counseling Services and Education
  18. Tobacco/Screening Services
  19. Facility Smoking Policy
  20. Age Groups Accepted
  21. Gender Accepted
  22. Exclusive Services
  23. Services for deaf

Here are the full facility listing details on Gateway Foundation Swansea in Belleville, IL:

Types of Care at Gateway Foundation Swansea

  • Detoxification
  • Substance use treatment
  • Treatment for co-occurring serious mental health illness/serious emotional disturbance and substance use disorders

Service Settings at Gateway Foundation Swansea

  • Outpatient treatment
  • Outpatient detoxification
  • Intensive outpatient treatment
  • Outpatient methadone/buprenorphine or naltrexone treatment
  • Regular outpatient treatment

Opioid Medications used in Treatment at Gateway Foundation Swansea

  • Buprenorphine used in Treatment
  • Naltrexone used in Treatment

Type of Alcohol Use Disorder Treatment at Gateway Foundation Swansea

  • This facility administers/prescribes medication for alcohol use disorder

Type Of Treatment at Gateway Foundation Swansea

  • buprenorphine detox
  • buprenorphine maintenance
  • suboxone prescription
  • naltrexone administration
  • relapse prevention from naltrexone

Pharmacotherapies at Gateway Foundation Swansea

  • Acamprosate (Campral)
  • Buprenorphine with naloxone (Ex. Suboxone)
  • Buprenorphine without naloxone
  • Naltrexone (oral)
  • Naltrexone (extended-release, injectable naltrexone - Vivitrol)
  • Medications for psychiatric disorders

Treatment Approaches at Gateway Foundation Swansea

  • anger management
  • brief intervention
  • cognitive behavioral therapy
  • contingency management/motivational incentives
  • community reinforcement plus vouchers
  • dialectical behavior therapy
  • motivational interviewing
  • matrix Model
  • rational emotive behavioral therapy
  • relapse prevention
  • substance use counseling
  • trauma-related counseling
  • 12-step facilitation

FacilityOwnership at Gateway Foundation Swansea

  • a private non-profit organization

License/Certification/Accreditation at Gateway Foundation Swansea

  • State substance abuse agency
  • The Joint Commission
  • National Committee for Quality Assurance

Payment/Insurance/Funding Accepted at Gateway Foundation Swansea

  • Federal, or any government funding for substance use programs
  • Medicaid
  • Private health insurance
  • Cash or self-payment
  • State-financed health insurance plan other than Medicaid

Special Programs/ Population Groups Supported at Gateway Foundation Swansea

  • adult women
  • adult men
  • people with co-occurring substance use and mental disorders

Assessment/Pre-treatment at Gateway Foundation Swansea

  • Comprehensive substance use assessment
  • Interim services for clients
  • Outreach to persons in the community

Screening & Testing at Gateway Foundation Swansea

  • Breathalyzer or blood alcohol testing
  • Drug or alcohol urine screening
  • Screening for mental disorders
  • Screening for substance use

Transitional Services at Gateway Foundation Swansea

  • Aftercare/continuing care
  • Discharge Planning
  • Naloxone and overdose education
  • Outcome follow-up after discharge

Ancillary Services at Gateway Foundation Swansea

  • case management
  • domestic violence services
  • mental health services
  • social skills development
  • transportation assistance

Detoxification at Gateway Foundation Swansea

  • alcohol detox
  • opioid detox

Counseling Services and Education at Gateway Foundation Swansea

  • individual counseling
  • group counseling
  • family counseling
  • substance use education

Tobacco/Screening Services at Gateway Foundation Swansea

  • Screening for tobacco use
  • Smoking/tobacco cessation counseling

Facility Smoking Policy at Gateway Foundation Swansea

  • Smoking permitted in designated area

Age Groups Accepted at Gateway Foundation Swansea

  • children and adolescents

Gender Accepted at Gateway Foundation Swansea

  • women
  • men

Exclusive Services at Gateway Foundation Swansea

  • Specially designed program for DUI/DWI clients

Services for deaf at Gateway Foundation Swansea

  • Services for the deaf and hard of hearing are available

Phone #: 618-234-9002

Call (866) 434-2077 for 24/7 help with treatment.

SPONSORED AD

Is Methadone a safe option for addiction treatment?

Methadone treatment can be a safe and effective option for individuals struggling with opioid addiction, especially when administered under the supervision of a qualified healthcare provider as part of a comprehensive addiction treatment program, such as the one that can be found at Gateway Foundation Swansea. Methadone is an opioid medication that is used to help manage opioid withdrawal symptoms and cravings, making it easier for individuals to reduce or quit their use of other opioids like heroin or prescription painkillers.

Here are some key points to consider regarding the safety of methadone treatment:

  1. Supervised Administration: Methadone treatment is typically provided through opioid treatment programs (OTPs) or clinics where patients receive a daily dose of methadone under the supervision of healthcare professionals. This helps reduce the risk of misuse and overdose.

  2. Reduces Withdrawal Symptoms: Methadone can alleviate the severe withdrawal symptoms associated with opioids, which can be a significant barrier to recovery. This can enhance the patient's quality of life and make it easier for them to engage in therapy and counseling.

  3. Harm Reduction: Methadone maintenance treatment can be viewed as a harm reduction approach. While it doesn't necessarily lead to immediate abstinence, it reduces the risks associated with illicit opioid use, such as overdose and the transmission of infectious diseases (e.g., HIV and hepatitis).

  4. Individualized Treatment: Methadone treatment should be individualized to meet the unique needs of each patient. The dose is typically adjusted based on the patient's response and progress in treatment.

  5. Legal Regulation: Methadone clinics and providers are subject to strict regulations and oversight by government agencies to ensure safety and appropriate use of the medication.

However, it's important to note that methadone is an opioid itself and can be habit-forming. When taken as prescribed and under medical supervision, the risk of addiction to methadone is relatively low. However, misuse or diversion of methadone can lead to addiction and other negative consequences.

Methadone treatment is not suitable for everyone. Individuals with certain medical conditions or contraindications may not be candidates for methadone treatment. It's essential for addiction treatment centers like Gateway Foundation Swansea to conduct a thorough assessment before starting someone on methadone.